The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
89BIO INC | COM | 282559103 | 3,046,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
89BIO INC | COM | 282559103 | 551,326 | 36,200 | SH | Call | SOLE | 36,200 | 0 | 0 | |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 1,044,419 | 129,100 | SH | Call | SOLE | 129,100 | 0 | 0 | |
ADC THERAPEUTICS SA | SHS | H0036K147 | 1,170,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 1,913,719 | 247,891 | SH | SOLE | 247,891 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 2,308,600 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 6,249,316 | 202,834 | SH | SOLE | 202,834 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 4,005,235 | 10,750 | SH | SOLE | 10,750 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 4,288,800 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 4,164,600 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
ASTRAZENECA PLC | SPONSORED ADR | 046353108 | 3,470,500 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 7,040,608 | 529,369 | SH | SOLE | 529,369 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 6,345,569 | 881,329 | SH | SOLE | 881,329 | 0 | 0 | ||
BIOATLA INC | COM | 09077B104 | 871,000 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 2,431,000 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 7,410,000 | 10,000,000 | PRN | SOLE | 10,000,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | 10806XAD4 | 7,120,872 | 11,000,000 | PRN | SOLE | 11,000,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 6,462,884 | 389,800 | SH | Put | SOLE | 389,800 | 0 | 0 | |
BRIDGEBIO PHARMA INC | COM | 10806X102 | 5,305,600 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 1,799,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADR | 152309100 | 2,633,889 | 684,127 | SH | SOLE | 684,127 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 9,268,200 | 380,000 | SH | SOLE | 380,000 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 22,594,886 | 976,021 | SH | SOLE | 976,021 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 1,543,661 | 143,064 | SH | SOLE | 143,064 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 9,444,789 | 1,083,118 | SH | SOLE | 1,083,118 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 7,793,283 | 221,463 | SH | SOLE | 221,463 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | NOTE 4.000%11/1 | 29664WAB1 | 3,008,250 | 7,500,000 | PRN | SOLE | 7,500,000 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 556,500 | 350,000 | SH | Put | SOLE | 350,000 | 0 | 0 | |
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 7,669,794 | 113,224 | SH | SOLE | 113,224 | 0 | 0 | ||
FOGHORN THERAPEUTICS INC | COM | 344174107 | 847,980 | 136,771 | SH | SOLE | 136,771 | 0 | 0 | ||
GLYCOMIMETICS INC | COM | 38000Q102 | 378,000 | 300,000 | SH | Put | SOLE | 300,000 | 0 | 0 | |
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 2,182,800 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 269,574 | 187,204 | SH | SOLE | 187,204 | 0 | 0 | ||
INARI MED INC | COM | 45332Y109 | 1,234,800 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
INOZYME PHARMA INC | COM | 45790W108 | 4,307,791 | 751,796 | SH | SOLE | 751,796 | 0 | 0 | ||
JASPER THERAPEUTICS INC | COM | 471871103 | 863,276 | 476,948 | SH | SOLE | 476,948 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 1,637,175 | 208,292 | SH | SOLE | 208,292 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 2,270,500 | 12,500 | SH | SOLE | 12,500 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 1,793,208 | 460,979 | SH | SOLE | 460,979 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 4,369,620 | 357,287 | SH | SOLE | 357,287 | 0 | 0 | ||
LANTHEUS HLDGS INC | COM | 516544103 | 2,496,945 | 30,244 | SH | SOLE | 30,244 | 0 | 0 | ||
LIANBIO | SPONSORED ADR | 53000N108 | 1,267,500 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 22,530,180 | 93,000 | SH | SOLE | 93,000 | 0 | 0 | ||
MERCK & CO INC | COM | 58933Y105 | 12,766,800 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 785,565 | 199,382 | SH | SOLE | 199,382 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COM | 603170101 | 978,750 | 62,500 | SH | SOLE | 62,500 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 2,281,900 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
MODERNA INC | COM | 60770K107 | 5,375,300 | 35,000 | SH | Call | SOLE | 35,000 | 0 | 0 | |
MORPHIC HLDG INC | COM | 61775R105 | 5,113,883 | 135,863 | SH | SOLE | 135,863 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | 68,450 | 37,000 | SH | SOLE | 37,000 | 0 | 0 | ||
NLS PHARMACEUTICS LTD | SHS | H57830103 | 519,574 | 344,089 | SH | SOLE | 344,089 | 0 | 0 | ||
NOVAVAX INC | COM NEW | 670002401 | 2,403,324 | 346,800 | SH | Put | SOLE | 346,800 | 0 | 0 | |
NURIX THERAPEUTICS INC | COM | 67080M103 | 1,332,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 415,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
PIERIS PHARMACEUTICALS INC | COM | 720795103 | 299,583 | 306,950 | SH | SOLE | 306,950 | 0 | 0 | ||
POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 1,087,490 | 149,586 | SH | SOLE | 149,586 | 0 | 0 | ||
PRECIGEN INC | NOTE 3.500% 7/0 | 46122TAA0 | 1,465,511 | 1,500,000 | PRN | SOLE | 1,500,000 | 0 | 0 | ||
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 16,098,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 548,008 | 177,349 | SH | SOLE | 177,349 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 77313F114 | 12,255 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | 738,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
SCILEX HOLDING CO | *W EXP 11/10/202 | 80880W114 | 19,004 | 18,099 | SH | SOLE | 18,099 | 0 | 0 | ||
SCILEX HOLDING CO | COM | 80880W106 | 3,797 | 463 | SH | SOLE | 463 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 4,049,400 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
SPDR S&P 500 ETF TRTR UNIT | TR UNIT | 78462F103 | 18,422,550 | 45,000 | SH | Call | SOLE | 45,000 | 0 | 0 | |
THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 872,202 | 98,221 | SH | SOLE | 98,221 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 2,332,118 | 62,223 | SH | SOLE | 62,223 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 8,710,268 | 260,008 | SH | SOLE | 260,008 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADR | 925050106 | 9,092,646 | 452,821 | SH | SOLE | 452,821 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 10,360,446 | 622,249 | SH | SOLE | 622,249 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 1,563,435 | 93,900 | SH | Put | SOLE | 93,900 | 0 | 0 | |
VINCERX PHARMA INC | COM NEW | 92731L106 | 1,552,482 | 1,492,771 | SH | SOLE | 1,492,771 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 2,556,720 | 100,500 | SH | Call | SOLE | 100,500 | 0 | 0 | |
XENON PHARMACEUTICALS INC | COM | 98420N105 | 3,221,100 | 90,000 | SH | SOLE | 90,000 | 0 | 0 |